Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Zhangyong Ren"'
Autor:
Zhangyong Ren, Bing Pan, Fangfei Wang, Shaocheng Lyu, Jialei Zhai, Xiumei Hu, Zhe Liu, Lixin Li, Ren Lang, Qiang He, Xin Zhao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundUnderstanding the spatial heterogeneity of the tumor microenvironment (TME) in pancreatic cancer (PC) remains challenging.MethodsIn this study, we performed spatial transcriptomics (ST) to investigate the gene expression features across one
Externí odkaz:
https://doaj.org/article/22c1b79a26e044aab77c523ba02c9b60
Autor:
Zhangyong Ren, Songping Cui, Shaocheng Lyu, Jing Wang, Lin Zhou, Yanan Jia, Qiang He, Ren Lang
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundWith the advancement of vascular anastomosis techniques in recent years, radical surgery for tumors combined with venous vascular resection and reconstruction has been widely used. This study intends to establish two different rat vein repl
Externí odkaz:
https://doaj.org/article/b9be51b1403c4a9697c79b355df0dc89
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Background Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. Lymph node metastasis is widely accepted as an important prognostic factor for distal cholangiocar
Externí odkaz:
https://doaj.org/article/83491ea2dae941cf8037b87c3f07e79a
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 5, Pp 765-766 (2021)
Externí odkaz:
https://doaj.org/article/051818f25242497faf3bda045ed393bc
Autor:
Xinxue Zhang, Zhangyong Ren, Junming Xu, Qing Chen, Jun Ma, Zhe Liu, Jiantao Kou, Xin Zhao, Ren Lang, Qiang He
Publikováno v:
Journal of Oncology.
Micro(mi)RNAs play an essential role in the epithelial-mesenchymal transition (EMT) process in human cancers. This study aimed to uncover the regulatory mechanism of miR-1301-3p on EMT in pancreatic cancer (PC). The miRNA profilings from Gene Express
Publikováno v:
Langenbeck's archives of surgery. 406(6)
Pancreaticoduodenectomy combined with portal vein resection for distal cholangiocarcinoma is rarely reported because it is a rare disease. We developed a program to evaluate the vascular invasion type, operation procedure, and long-term survival of d
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 5, Pp 765-766 (2021)
BACKGROUND: Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. And the 5-year survival rate of distal cholangiocarcinoma after pancreatoduodenectomy ranged from 22–47%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20e3a35c063dec05ee7300a5af58bf71
https://doi.org/10.21203/rs.3.rs-33592/v1
https://doi.org/10.21203/rs.3.rs-33592/v1
Publikováno v:
World Journal of Surgical Oncology
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Background Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. Lymph node metastasis is widely accepted as an important prognostic factor for distal cholangiocarcinoma. T
Autor:
Qiang He, Xin Zhao, Shaocheng Lv, Lixin Li, Jiqiao Zhu, Zhangyong Ren, Ren Lang, Di Cao, Zhe Liu
Publikováno v:
Bioscience Reports
Background: Hypermethylation of gene promoters plays an important role in tumorigenesis. The present study aimed to identify and validate promoter methylation-driven genes (PMDGs) for pancreatic ductal adenocarcinoma (PDAC). Methods: Based on GSE4914